Intelligent OMICS partners with Janssen on AI-driven research
The AI platform and expertise will be combined to discover novel targets for haematological cancers
Read Moreby John Pinching | Sep 1, 2023 | News | 0
The AI platform and expertise will be combined to discover novel targets for haematological cancers
Read Moreby John Pinching | Aug 2, 2023 | News | 0
The deal covers 13 brands across six therapeutic areas, mainly focused on pain treatment
Read Moreby John Pinching | Jun 23, 2023 | News | 0
Companies’ precision medicine approach has potential to increase clinical trial success rates
Read Moreby John Pinching | May 2, 2023 | News | 0
Deal involves an oral BET inhibitor which treats fibrotic and immuno-inflammatory disorders
Read Moreby John Pinching | Apr 26, 2023 | News | 0
Vital link-up aims to expand ColoAlert detection tests in Europe and increase early cancer diagnosis
Read Moreby John Pinching | Mar 31, 2023 | News | 0
Collaboration comes after renewed focus on key therapeutic areas of immunology and oncology
Read Moreby John Pinching | Mar 17, 2023 | News | 0
GOSH will collaborate with Leucid at the Zayed Centre for Research into Rare Disease in Children
Read Moreby John Pinching | Mar 15, 2023 | News | 0
Duo team up for the development of antigen-targeted probes for early cancer detection
Read Moreby John Pinching | Mar 8, 2023 | News | 0
Collaboration will focus on innovative therapies for patients with a range of respiratory diseases
Read Moreby John Pinching | Feb 13, 2023 | News | 0
Partnership will focus on essential new therapies across neurodegenerative diseases
Read Moreby John Pinching | Dec 7, 2022 | News | 0
Partnership aims to progress personalised cancer therapy by incorporating doggybone DNA
Read Moreby John Pinching | Oct 28, 2022 | News | 0
PhoreMost to deploy its Siteseeker protein platform to enable drug discovery
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
